Vaxcyte, Inc. (PCVX) vs Praxis Precision Medicines, Inc. (PRAX)

Vaxcyte, Inc. and Praxis Precision Medicines, Inc. are both Biotechnology companies. Vaxcyte, Inc. and Praxis Precision Medicines, Inc. are of similar size ($8.5B and $7.9B). Across the 10 metrics below, Praxis Precision Medicines, Inc. leads on 6 and Vaxcyte, Inc. on 4.

Valuation

Metric PCVX PRAX Biotechnology median
P/E n/m n/m 7.88
P/S n/m 956.32 11.47
P/B 2.95 6.10 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 867.63 10.73
Earnings yield (13.57%) (4.61%) (28.84%)
Free cash flow yield (11.01%) (3.74%) (23.03%)

Profitability

Metric PCVX PRAX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.51%) (38.86%) (57.72%)
Return on assets (33.03%) (36.80%) (49.22%)
Return on invested capital (57.30%) (40.58%) 0.00%

Growth

Metric PCVX PRAX Biotechnology median
Revenue growth (TTM) — 249.53% 5.64%
EPS growth (last fiscal year) (48.16%) (32.03%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PCVX PRAX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.72 15.73 4.73
Net debt to EBITDA 1.71 1.82 0.96

Dividend

Metric PCVX PRAX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PCVX PRAX Biotechnology median
Market cap 8.47b 7.87b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack